Blogs
It’s the middle of February so we all know what that means – red hearts everywhere to celebrate a special holiday. If you’re thinking about Valentine’s Day, you wouldn’t be wrong. But this week we are recognizing another heart-based campaign – Heart Failure Awareness Week. In 2001 the Heart Failure Society of America, with support…
After a yearlong tremendously successful equity crowdfunding campaign, the ability to acquire equity in BIOLIFE4D and participate in the groundbreaking technology is quickly coming to an end. There are now only 24 hours left to invest in BIOLIFE4D before the opportunity to do so closes – this Thursday January 31, 2019! Earlier this weekwe announced the appointment…
We’re down to the wire. In just one week we’ll be closing the opportunity to invest in BIOLIFE4D through our equity crowdfunding campaign. This is your last chance to be able to participate with us in bringing this incredible technology to the market. It is your last chance to get in on the ground floor…
Heart disease kills more human beings than anything else on earth each year, accounting for 18 million deaths – about 31% of all global deaths. Solving heart disease has been one of humanity’s greatest challenges since the beginning of medicine but sadly, scientists have not been able to figure it out. The impact of deaths from…
The beginning of each year is a great time to get a lot of things in order, and one of those is finances and investments. Many people invest in vehicles like index funds that spread their money across a large number of companies, and often don’t keep track of where their money goes. At the…
January 2019 is the final month to invest in BIOLIFE4D’s Regulation A+ offering to participate in the groundbreaking technology of 3D bioprinting human hearts viable for transplant. If you’re not familiar, in February 2018, BIOLIFE4D launched this offering to allow both accredited and non-accredited potential investors to consider helping us bring this historical, lifesaving technology…
It’s that time of the year again: the end – and many people will use this time to look back at how they lived this year, and how they can better themselves in the next. In addition to finding new ways to help themselves, many people will think about new ways that they can help…
In our efforts to save human lives by fighting heart disease and heart shortages, 2018 was our busiest year to date. With the help of a world-class team and forward-thinking investors, we have already made major scientific and biological strides and hope to begin bringing our incredible technology to the market by the end of…
In February of this year, we announced our Regulation A+ crowdfunding campaign to give everyone the opportunity to invest in BIOLIFE4D and share our mission to change the way heart disease is treated forever. We’ve received a tremendous amount of support throughout the year from our investors and are thankful to be working with each…
The first heart transplant in human history took place on December 3, 1967, which means earlier this week we celebrated the 51st anniversary of the heart transplant. The heart transplant process has improved significantly in that time, perhaps most importantly the survival rate of transplant recipients. However, one aspect that still requires improvement is the…
The end-of-year holiday season brings families and friends together, and many people will be asked by loved ones what they would like to receive as gifts. These gifts can thoughtfully demonstrate an understanding of what the recipients enjoy or what matters most to them. To find these gifts, many people will head to shopping malls or…
If you’re reading this, it is because you’ve lived healthily enough to reach another Thanksgiving. Everyone is thankful for something and in this case, you may be thankful that you and your loved ones are all together once more. None of this would be possible, though, without beating hearts. Unfortunately, there is a shortage of…
Many people know someone who – for one reason or another – wishes they invested in a company very early in its existence. One of the major benefits of investing in a company early is that if it’s successful, you will likely have bought in at a low price and your securities will be worth…
Less than six months ago we announced our residency at the Johnson & Johnson Innovation JLABS at the renowned Texas Medical Center in Houston, Texas. Since that time, through the access of state-of-the-art equipment and support, we have been able to accelerate our scientific roadmap, successfully 3D bioprinting a human cardiac patch significantly ahead of schedule. Following…
In addition to working on our 3D bioprinted mini human heart, October has been a busy month for BIOLIFE4D with media coverage in the Houston Chronicle, Arkansas Democrat-Gazette, Medical Device and Diagnostics Industry (MDDI) and 3Dnatives. We’re thrilled with the continued support of our efforts, and hope our investors feel the same way. Whether you’re…
As humans have evolved, so too has our understanding of our bodies and how we can enhance, repair or extend life. Since the dawn of time, humanity has encountered disease and other external circumstances that require medical innovation and care. Even for seemingly irreplaceable parts of the body and organs, we have a knack for…
Diversification is a widely-practiced investment strategy in which investors and asset managers assemble portfolios containing various stocks and other kinds of assets – some high-risk, low-risk and even passion projects for social good – to increase their chances at greater returns. You may be a savvy investor, but chances are your portfolio doesn’t already include securities…
Earlier this year, BIOLIFE4D established operations in Houston, Texas, to continue developing our medical technology, and to take significant strides toward our goal of 3D bioprinting a human heart viable for transplant. As a Johnson & Johnson JLABS resident at Texas Medical Center, we have access to world-class laboratory facilities, making the city of Houston’s…
Investments come in many different forms – real estate, stocks, bonds and crowdfunding, to name a few. Across all forms, a movement gaining a lot of momentum in recent years has been ethical investing. Ethical investing often involves avoiding investments in controversial companies or projects. Many advisors and retirement plans offer ethical investing options that will…
In case you didn’t already know, this Saturday, September 29 marks World Heart Day. Created by the World Heart Federation, this date serves to raise awareness of cardiovascular disease, the world’s leading killer. This education centers around preventative measures individuals can take to reduce their own risk of cardiovascular disease – like diet and exercise – but…
We’ve recently shared more recognition of BIOLIFE4D and our scientific innovation in the global media, as outlets like BBC showcased our life-saving technology. Today we’re pleased to announce that we were recently recognized as a nominee for the 17th Annual Chicago Innovation Awards, held each year to celebrate innovators within the Chicago-ecosystem. BIOLIFE4D was nominated in…
Summer may be winding down, but BIOLIFE4D’s efforts to 3D bioprint a human heart viable for transplant are not and the media has taken notice. These efforts have attracted international attention, as evidenced by recent features in the BBC and on Verdict. We haven’t forgotten our roots, though, as 3DPrint.com and Medical Device Network have…
In addition to marking the end of summer and bringing cooler weather in many places, September is Healthy Aging Month and a great time to think about how you can age like a fine wine. Your heart is perhaps the most important organ in your body and if you want it to take care of you,…
As BIOLIFE4D works to 3D bioprint a full-size human heart viable for transplant, we have an opportunity to complete several incremental achievements, each of which not only validates our technology and process but also provides huge market potential while on our way to developing the full heart. Scientifically, one of our first steps was to…
Although humans have been transplanting hearts for 50 years, a heart transplant is still an incredibly complicated procedure posing some major challenges – the available supply of transplantable hearts, getting a recipient’s body to accept another human being’s heart, and having world-class medical facilities and personnel to execute the procedure. The heart is one of,…
As you are probably aware by now, one of the greatest challenges facing the organ transplant industry is a shortage of organs available for transplant. It’s possible to live without some organs – like kidneys – and so those can be donated by living donors. However, most organs are vital, and are required for survival….
When BIOLIFE4D successfully 3D bioprinted human cardiac tissue, two of the main reasons we were excited were that it’s obviously a significant medical milestone, and because we did it well ahead of our initial schedule. With that said, we’ve followed it up by aiming even higher, and are now laser-focused in our labs on 3D…
As of April 2018, the U.S. organ transplant waiting list was about 114,000 names long, while less than 35,000 transplants were performed in 2017. Overall, about one third of the total demand is being met, and when that happens, people often resort to illegal means to secure organs. As a result, 5-10% of all organ transplants…
At BIOLIFE4D, we’re working to 3D bioprint human organs viable for transplant from patients’ own cells. That work is very complex and quite frankly, so is the market for this kind of technology. Each year, many different types of organs are transplanted, each of which are affected by unique supply challenges and thus present different…
In case you missed it, BIOLIFE4D recently successfully demonstrated its ability to 3D bioprint human cardiac tissue derived from stem cells, which it had reprogrammed from an individual’s specialized cells into the different types of heart cells needed to bioengineer a human heart. And astonishingly, we 3D bioprinted our human cardiac patch more than a year…
Since we announced our Regulation A+ equity crowdfunding campaign back in February, we have been met with tremendous support and enthusiasm from individuals who felt connected to the cause and wanted to help. Nearly five months later the support from our investors continues, but we’ve also attracted a host of new eyes toward our company…
It’s been a hot week as we roll in to July, and BIOLIFE4D set off some early fireworks with media features in two prominent publications – Popular Mechanics and Crain’s Chicago Business! Both of these highly influential news outlets featured our scientific milestone achievements from last week. We couldn’t be more proud to see the…
Earlier this week, we shared with the world that BIOLIFE4D has achieved an incredible scientific milestone, having successfully 3D bioprinted human cardiac tissue. In the days since the announcement, we’ve received tremendous feedback and the world has certainly taken notice. Below are a selection of some of the pieces of media coverage we’ve achieved this…
We are extremely excited to announce that BIOLIFE4D has successfully demonstrated its ability to 3D bioprint viable human cardiac tissue – specifically, a human cardiac patch. And what is just as incredible it that our science team, which is located at the prestigious research facility at JLABS, was able to accomplish this feat far ahead…
Today is an exciting day for BIOLIFE4D. After just a few months and more than $1M in investments raised, we’re pleased to announce that we’ve modified our Regulation A+ (Mini-IPO) offering due to popular demand and that the stock price has now reached $12 per share – a 20% increase in just four months. Since…
BIOLIFE4D stands on the precipice of a technology breakthrough that we truly believe will alter the way potential partners and investors consider our company. From Day 1, we have done our best to outline a clear strategy so that our shareholders, partners and interested parties would understand our vision. From there, it has been on us…
It is with great pleasure that I announce the opening of BIOLIFE4D research labs at JLABS, within the Texas Medical Center, Houston. After several months of strategy planning, BIOLIFE4D is now positioned in the heart of the world’s largest medical center, Texas Medical Center. Houston is the mecca of heart research and is home to…
The last several months have been an incredible time for BIOLIFE4D. In February, we launched our equity crowdfunding campaign to help in our mission to 3D bioprint viable treatment alternatives to cardiac issues, like patches, valves, and full hearts for transplant. Our scientific achievements are progressing rapidly, and the media has certainly taken notice. We have…
You’ve likely heard that BIOLIFE4D is currently raising funds to 3D bioprint transplantable human hearts, valves, and other organs. In order to do that, we need people like you to be aware of what we’re working towards. If these stories have you excited and you want to spread the word, we’d love you to share…
When investing, it is important to consider companies and ventures that address common problems. Unfortunately, heart disease is an extremely common problem, as in the U.S. it kills one in three women and one in four men each year. In the developed world as a whole, it kills one in three people. Because there are…
If you’re like many Americans, you may have recently received your federal and state tax returns. People use these sudden windfalls of money for lots of different things. Some spend it all in short shopping sprees, while others use it to pay bills or stow it away in savings. If you’re interested in improving your…
As many know, February was American Heart Month. First recognized in 1964, Heart Month has gone on to serve as a reminder to Americans how important heart health is to themselves, their families, and their friends. It’s an important reminder too – heart disease is the #1 killer of men and women in the U.S….
This Sunday, April 15 is Good Deeds Day, when people celebrate by doing good deeds for others and for the world. Established in 2007, Good Deeds Day has become an annual tradition in 93 countries, based on the idea that everyone is capable of doing good. In 2017, 2.5 million participants helped with about 20,000…
BIOLIFE4D is pleased to announce today the availability of two new investment methods – mobile device and debit/credit cards! Investing in BIOLIFE4D has never been easier, as we have now expanded our solutions to provide investors with multiple options for investment. Mobile Devices In addition to laptop and desktop computers, investors can now utilize their…
Aside from the recent holidays and April fools, this week also officially kicked off National Donate Life Month, a period dedicated to encouraging Americans to register as organ, eye and tissue donors and to honor those donors who have impacted the lives of others. According to the Organ Procurement and Transplantation Network, every ten minutes,…
As of March 21, spring is in the air. On top of taking advantage of the warmer weather and additional daylight, people like to clean. People clean their cars, yards, floors, gutters, closets – you name it. But this year, why don’t you make it a goal to spring clean your arteries, your heart, and…
By now you’re aware of BIOLIFE4D’s mission to transform the way heart disease is treated and to save lives by innovating the transplant process. Through our revolutionary 3D bioprinting process, we will produce viable human organs for transplant and provide a higher quality of life for patients. However, there is another group that we are…
Last Sunday the majority of the United States observed Daylight Savings Time, which for many means we’re getting closer to Spring and warmer weather. For one night though, it also meant one less hour of sleep (to the chagrin of many). Daylight Savings Time can affect sleeping rhythms, as it gets dark later and light…
It’s been about a month since we opened up our Regulation A+ equity crowdfunding campaign for investment and as our CEO Steve Morris noted recently, the response has been incredible. We’ve been accepting new investments every day and our group of public shareholders is growing! It really has been an incredible few weeks. To date,…
As warmer weather approaches (for those of us in multi-seasonal areas), stepping outside becomes more enticing. Many of us have likely spent the colder months hibernating inside, indulging on too many delicious holiday snacks. Even if you’re not ready to get working on your beach bod, now is a great time to get back outside…
Two weeks ago, we took a significant step toward our mission of revolutionizing treatment for heart disease when we launched our Regulation A+ equity crowdfunding campaign. The decision to allow outside investment by the general public into BIOLIFE4D was an easy one. Heart disease has touched the lives of tens of millions of people across…
It’s that time of the year again: Valentine’s Day when we celebrate our significant others, loved ones, and families. It’s also Heart Month! Since love is such a major theme of this holiday and of this time of year, we’ve put together a list of eight songs – some older, some newer – that will…
February is an important time of year for the heart, but not for the reason you might be thinking of. Sure, there’s that holiday about love and emotions from the heart, but we’re talking about something much more significant. February is American Heart Month – sponsored by The American Heart Association – and is the…
Heart failure and losing a loved one to sudden cardiac arrest is emotionally draining and something that no one should ever have to experience. Sadly, too many of us have been through this experience. The disparity between donor hearts and the number of patients requiring a heart transplant is staggering. There are only 3,000 donor…
It was December 24, 2014 when I first heard the words “heart failure.” I wasn’t feeling great but by no means did I think it was anything serious. I prided myself on healthy living and eating. January, 2015 was when I was first hospitalized for my condition and spent a total of 66 days in…
While many people associate cold weather dangers with hypothermia or frostbite, there’s more to it. According to Northwestern Medicine, falling temperatures increase risks for heart attacks. It can create dangerous combinations of cardiovascular risks, so it’s important to take steps to protect yourself. Like heart transplant waiting lists, winter heart health is a supply and…
*** The following contribution is from Virgil Anderson, a tireless advocate for awareness around workplace asbestos exposure, as well as someone who was diagnosed with mesothelioma *** 3D printing is revolutionizing many industries, but the possibility that this technology could print cells, tissues, and organs for human patients is perhaps the most exciting application. In fact,…
At each year’s end, people resolve to improve in certain aspects of their lives and make the new year better than the last. These resolutions range from financial to physical, and everything in between. If you need help with your resolution, allow BIOLIFE4D to recommend one: better heart health. If you take care of your…
Jack Radandt was born with a rare condition called Hypoplastic Left Heart Syndrome. The condition is a congenital heart defect affecting normal blood flow through the heart. Jack’s heart reconstruction process began at 10 days old, and his remaining two surgeries were performed before he reached the age of three. After the surgeries, he triumphed…
Ah, the holidays have finally arrived! Hanukah, Christmas, Kwanza, then New Year’s Eve and New Year’s Day itself are just around the corner. One of the best parts about the holiday season is the setting. In many parts of the United States and the Western Hemisphere snow falls and fireplaces are lit. This, coupled with…
The medical uses for 3D bioprinting are expanding rapidly and are expected to revolutionize health care. Medical uses for 3D bioprinting can be seen within several broad categories, including tissue and viable human organ fabrication. These applications for 3D bioprinting can provide many benefits could include the customization and personalization of the actual tissue and organs using…
Earlier this week, on December 3, 2017, the medical community celebrated the 50th anniversary of one of the most historic events ever – the first ever human heart transplant. It’s been 50 years since Dr. Christiaan Barnard performed the procedure on 53-year old Lewis Washkansky, a South African grocer dying of heart disease. Though Washkansky…
As a whole, the organ transplant industry isn’t perfect. But its biggest problem isn’t in surgeries; it’s in the limited supply and seemingly endless demand for the most necessary component — the organ itself. At any given time, tens of thousands of people are on waiting lists for heart and organ transplants. Sadly, many of…
Each year, we come together with friends and family on Thanksgiving Day to, well, give thanks. In addition to giving thanks for our loved ones, we express gratitude for tables full of food, and eat more than we normally would. While you may want to eat at least some of everything on the table in…
Roxanne Watson is an amazing woman. She’s just one of millions who have been affected by heart disease globally. But she’s putting her personal story of struggle and triumph to work for others in a major way. After spending two agonizing years on the heart transplant waiting list, Roxanne was able to get the heart…
Sadly, heart disease remains the number one killer in the developed world. It’s the leading cause of death for both men and women. What about cancer? Cardiovascular diseases actually surpass the annual mortality rate of all types of cancer combined. Patients in the late stages of heart failure or severe coronary artery disease can be…
To the layman, “3D bioprinting” may be a strange term that conjures up futuristic images of science fiction. But the fascinating reality is that 3D bioprinting is indeed science fact, and it’s built on a history of advancements across a number of life science and technological disciplines. There’s the biological aspect, which dates back to…
